Bioanalytical Assays to Support COVID-19 Drug Development

Bioanalytical Assays to Support COVID-19 Drug Development

Contract Research

Information

Celerion, a leader in early clinical research services and clinical bioanalysis industry, is a global company with over 50 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the confidence to make fast, accurate decisions about their drug development. Celerion has created a compelling bioanalytical offering to support drug development at all stages, from in vitro metabolite identification to human ADME profiling studies. We focus on traditional small molecule, large molecule and a variety of niche bioanalytical technologies.
CelerionCelerion, a leader in early clinical research services and clinical bioanalysis, is a global company with over 50 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the guidance to make fast, accurate decisions about their drug development. Celerion has proven experience across a variety of vaccines, including different routes of administration, and patient populations. Our track record spans both preventive and therapeutic vaccines, subunit, and conjugates across all phases I-IV in more than 20 countries, 300 study centers and 4500 subjects.

Log in